Education
About Us
Working with TipRanks
Follow Us
Resonance Health Ltd (AU:RHT)
ASX:RHT
RESEARCH TOOLSreports
Total Valuation
Resonance Health Ltd has a market cap or net worth of AU$16.55M. The enterprise value is AU$23.51M.
Market CapAU$16.55M
Enterprise ValueAU$23.51M
Share Statistics
Resonance Health Ltd has 459,616,150 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding459,616,150
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Resonance Health Ltd’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is 1.62%.
Return on Equity (ROE)0.02
Return on Assets (ROA)<0.01
Return on Invested Capital (ROIC)1.62%
Return on Capital Employed (ROCE)-0.06
Revenue Per Employee477.19K
Profits Per Employee9.41K
Employee Count18
Asset Turnover0.42
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Resonance Health Ltd is 158.93. Resonance Health Ltd’s PEG ratio is -1.29.
PE Ratio158.93
PS Ratio0.00
PB Ratio2.46
Price to Fair Value2.46
Price to FCF26.64
Price to Operating Cash Flow19.40
PEG Ratio-1.29
Income Statement
In the last 12 months, Resonance Health Ltd had revenue of 8.59M and earned 169.30K in profits. Earnings per share was 0.00.
Revenue8.59M
Gross Profit8.59M
Operating Income-879.47K
Pretax Income-626.89K
Net Income169.30K
EBITDA-381.53K
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was 2.53M and capital expenditures -124.92K, giving a free cash flow of 2.41M billion.
Operating Cash Flow2.53M
Free Cash Flow2.41M
Free Cash Flow per Share<0.01
Dividends & Yields
Resonance Health Ltd pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.90
52-Week Price Change-50.00%
50-Day Moving Average0.04
200-Day Moving Average0.05
Relative Strength Index (RSI)12.67
Average Volume (3m)274.47K
Important Dates
Resonance Health Ltd upcoming earnings date is Aug 28, 2025, TBA Not Confirmed.
Last Earnings DateFeb 27, 2025
Next Earnings DateAug 28, 2025
Ex-Dividend Date―
Financial Position
Resonance Health Ltd as a current ratio of 1.51, with Debt / Equity ratio of 35.84%
Current Ratio1.51
Quick Ratio1.51
Debt to Market Cap0.12
Net Debt to EBITDA8.28
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Resonance Health Ltd has paid -796.19K in taxes.
Income Tax-796.19K
Effective Tax Rate1.27
Enterprise Valuation
Resonance Health Ltd EV to EBITDA ratio is -62.25, with an EV/FCF ratio of 23.52.
EV to Sales2.76
EV to EBITDA-62.25
EV to Free Cash Flow23.52
EV to Operating Cash Flow17.12
Balance Sheet
Resonance Health Ltd has AU$3.51M in cash and marketable securities with AU$3.60M in debt, giving a net cash position of AU$84.91K billion.
Cash & Marketable SecuritiesAU$3.51M
Total DebtAU$3.60M
Net CashAU$84.91K
Net Cash Per Share<AU$0.01
Tangible Book Value Per Share<AU$0.01
Margins
Gross margin is 100.00%, with operating margin of -10.24%, and net profit margin of 1.97%.
Gross Margin100.00%
Operating Margin-10.24%
Pretax Margin-7.30%
Net Profit Margin1.97%
EBITDA Margin-4.44%
EBIT Margin-10.24%
Analyst Forecast
The average price target for Resonance Health Ltd is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast89.13%
EPS Growth Forecast69.57%